Scrip’s Five Must-Know Things – 26 July 2021

This week– J&J’s outlook for coronavirus vaccines, Cosentyx comes in strong for Novartis, Biogen’s views on Aduhelm pricing, competition in the “dustat” sector, and dealing with endemic COVID-19.